To amend the Federal Food, Drug, and Cosmetic Act with respect to the requirements for the small business waiver from device fees related to annual establishment registration, and for other purposes.

Scott Perry

Republican · PA · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the House Committee on Energy and Commerce.

2026-07-20

Source: Congress.gov

The proposal would change the rules for how small medical device companies qualify for a waiver that lets them avoid paying annual registration fees to the FDA. Currently, small businesses must meet certain size requirements to get this fee break, and this bill would adjust those requirements to help more small device manufacturers keep costs down. The changes would make it easier for smaller companies in the medical device industry to operate without the burden of these federal fees.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 9791 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 9791 To amend the Federal Food, Drug, and Cosmetic Act with respect to the requirements for the small business waiver from device fees related to annual establishment registration, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 20, 2026 Mr. Perry introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act with respect to the requirements for the small business waiver from device fees related to annual establishment registration, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Nullifying Overbearing Federal Expenditures and Exorbitant Spending Act of 2026'' or the ``NO FEES Act of 2026''. SEC. 2. SMALL BUSINESS FEE WAIVER. (a) Small Businesses Fee Waiver.-- (1) Definition of small business.--Section 738(a)(3)(B)(ii)(I) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)(B)(ii)(I)) is amended to read as follows: ``(I) Definition of small business.--For purposes of this clause, the term `small business' means an entity that employs less than 20 full- time equivalent employees, including such employees of all of its affiliates.''. (2) Waiver.--Section 738(a)(3)(B)(ii)(II) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)(B)(ii)(II)) is amended to read as follows: ``(II) Waiver.-- ``(aa) In general.--Subject to subclause (V), the Secretary shall grant a waiver of the fee required under subparagraph (A) for the annual registration of an establishment for a year if the Secretary finds that such establishment is a small business. ``(bb) Prohibition on secretary considering payment history.--In determining whether to grant a waiver under this clause, the Secretary may not consider whether an establishment paid the fee required under subparagraph (A) for any year prior to the year for which the establishment requests such waiver. ``(cc) Size and affiliation standards.--For purposes of determining whether an establishment is a small business under this clause, the Secretary shall apply the standards of the Small Business Administration related to size eligibility and affiliation, as described in sections 121.103 and 121.106 of title 13, Code of Federal Regulations (or successor regulations). ``(dd) Information demonstrating establishment size.--For purposes of demonstrating that an establishment requesting a waiver is a small business under this clause, such establishment shall submit to the Secretary, at least 60 days before the fee is due pursuant to subparagraph (C), a copy of its most recent Federal income tax return for a taxable year or its most recent payroll register.''. (3) Exclusion of foreign companies.--Section 738(a)(3)(B)(ii)(III) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)(B)(ii)(III)) is amended to read as follows: ``(III) Exclusion of foreign companies.--An entity that is organized under the laws of a foreign government may not-- ``(aa) apply for a waiver under this clause; or ``(bb) form an entity under the laws of the United States for purposes of applying for a waiver under this clause.''. (4) Waiver amount; expiration of eligibility.--Section 738(a)(3)(B)(ii) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)(B)(ii)) is amended by striking subclause (IV) and inserting the following: ``(IV) Waiver amount.--A waiver granted by the Secretary to an establishment under this clause shall cover-- ``(aa) with respect to the 3-year period beginning on the date on which the Secretary first determines that such establishment qualifies for such waiver, 100 percent of the amount of the fee required under subparagraph (A); and…

``(bb) with respect to the subsequent 2-year period, 50 percent of such amount. ``(V) Expiration of eligibility.-- The Secretary may not grant a waiver to an establishment under this clause following-- ``(aa) the date of a determination by the Secretary, if any, that such establishment is not a small business; or ``(bb) the expiration of the 5-year period of coverage applicable to such establishment under subclause (IV).''. (5) Non-reviewability.--Section 738(a)(3)(B)(ii)(V) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)(B)(ii)(V)) is amended by striking ``Request for waiver.--'' and all that follows through ``subparagraph (C).'' and inserting ``Non-reviewability.--''. SEC. 3. ANNUAL REGISTRATION FEE FOR FOREIGN COMPANIES. Section 738(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j(a)(3)) is amended by adding at the end the following: ``(D) Annual registration fee for foreign companies.--With respect to an establishment owned or operated by an entity organized under the laws of a foreign government, the fee for an initial or annual registration under section 510 shall be equal to the fee required under subparagraph (A) multiplied by 8.''. SEC. 4. EFFECTIVE DATE. The amendments made by this Act shall apply beginning on the date that is 90 days after the date of enactment of this Act. <all>

• HR9792To amend the Employee Retirement Income Security Act of 1974 to permit employee stock ownership plan participants to benefit from the full amount of beneficial ownership that can be accrued in the plan while also fully realizing the benefits of saving for retirement in a defined contribution plan.
  Referred to Committee · 2026-07-20
• HR9713No More Debt Relief to China Act
  Referred to Committee · 2026-07-15
• HR9687Blocking CCP Spy Tech Act of 2026
  Referred to Committee · 2026-07-14
• HR9480To amend the Internal Revenue Code of 1986 to allow a deduction for amounts contributed to home savings accounts, and for other purposes.
  Referred to Committee · 2026-06-25